The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...
Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...
CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback